Despite much recent progress in studies of the T cell repertoire and positive and negative selection, major gaps remain. Quantitative information on the average frequency of naive T cells specific for typical antigenic peptides associated with self-MHC molecules is extremely sparse, as is the magnitude of the bias of mature T cells towards self-MHC restriction at the level of precursor cell frequencies. The nature of the repertoire before the action of positive and negative selection is completely unexplored. The relative roles of hematopoietic cells versus thymic epithelial cells in inducing positive selection is still unclear.
Our first aim i s to employ libraries of MHC binding peptides to determine the average frequency of self-MHC restricted T cells among mature CD8+ T cells, as well as the magnitude of the bias towards self-MHC restriction imposed by positive selection.
Our second aim i s to determine the nature of the primary (pre-selection) repertoire in terms of MHC-reactivity and frequency of T cells specific for MHC associated peptides.
Our third aim i s to determine the rules for T cell positive selection by hematopoietic cells versus thymic epithelial cells. While the functions of conventional CD4+ and CD8+ T cells are relatively well understood, little is known concerning a discrete population of mature T cells that expresses the NK1.1 antigen. This population includes CD4-CD8-TCRalpha-beta+ cells as well as CD4+CD8~TCRalpha-beta+ cells. Both subsets have a strongly biased T cell receptor Vbeta and Valpha repertoire and our recent data demonstrates that the selection of these cells within the thymus requires class I expression, but is independent of class II expression. The developmental relation of these cells to conventional T cells is unknown.
Our fourth aim i s to address the role of specific TCR expression in directing the production of NK1.1 + T cells versus conventional T cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI030171-07
Application #
2065497
Study Section
Immunobiology Study Section (IMB)
Project Start
1991-01-01
Project End
2000-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
7
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California Berkeley
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
094878337
City
Berkeley
State
CA
Country
United States
Zip Code
94704
Coles, M C; Raulet, D H (2000) NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. J Immunol 164:2412-8
Zajac, A J; Vance, R E; Held, W et al. (1999) Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. J Immunol 163:5526-34
Kang, J; Coles, M; Raulet, D H (1999) Defective development of gamma/delta T cells in interleukin 7 receptor-deficient mice is due to impaired expression of T cell receptor gamma genes. J Exp Med 190:973-82
Zerrahn, J; Volkmann, A; Coles, M C et al. (1999) Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells. Proc Natl Acad Sci U S A 96:11470-5
Kang, J; Fehling, H J; Laplace, C et al. (1998) T cell receptor gamma gene regulatory sequences prevent the function of a novel TCRgamma/pTalpha pre-T cell receptor. Immunity 8:713-21
Raulet, D H; Correa, I; Corral, L et al. (1995) Inhibitory effects of class I molecules on murine NK cells: speculations on function, specificity and self-tolerance. Semin Immunol 7:103-7
Raulet, D H (1994) MHC class I-deficient mice. Adv Immunol 55:381-421
Correa, I; Corral, L; Raulet, D H (1994) Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur J Immunol 24:1323-31
Coles, M C; Raulet, D H (1994) Class I dependence of the development of CD4+ CD8- NK1.1+ thymocytes. J Exp Med 180:395-9
Bix, M; Coles, M; Raulet, D (1993) Positive selection of V beta 8+ CD4-8- thymocytes by class I molecules expressed by hematopoietic cells. J Exp Med 178:901-8

Showing the most recent 10 out of 12 publications